A new CAR-T therapy developed by London scientists has shown promise in treating an aggressive form of blood cancer. CAR-T ...

By Dr. Chinta Sidharthan Study links T-ALL tumor subpopulations to treatment failure, maps healthy pediatric blood ...

Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Tebbi has worked in Tampa for the last three decades and has been the director of the Children’s Cancer Research Group Laboratories since 2017. The research lab is funded and operated by the 1Voice ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset ...

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

On the 30th anniversary of the revolutionary memoir, Suleika Jaouad looks back at the book’s influence on her life and ...

ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.